JPRN-UMIN000004223
Completed
Phase 2
Feasibility study of Neoadjuvant chemoradiotherapy for locally advanced esophageal carcinoma - NeoCRT trial
ConditionsEsophageal Cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Esophageal Cancer
- Sponsor
- ational Cancer Center Hospital
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)active other malignancies within 5 years 2\)Pregnant or lactating women, women who are capable of pregnancy or intend to get pregnant, men who don't intend to have protected intercourse. 3\)Unsuitable mental status and condition for clinical trials. 4\)Patients who received ontinuous steroids (orally or intravenous) administration. 5\)Positive HBsAg. 6\)Unstable diabetes mellitus with oral hypoglycemic agent or insulin. 7\)Acute myocardial infarction within 3 months 8\)severe complications (COPD, interstitial lung disease, pulmonary fibrosis, heart failure and so on) 9\)clinically significant infectious disease(body temperature less than 38\.0 degrees) 10\)Any other cases who are regarded as inadequate for study enrollment by the investigator.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Feasibility study of neoadjuvant chemoradiotherapy using Intensity Modulated Radiation Therapy (IMRT) with Docetaxel, CDDP and 5-Fluorouracil (DCF) for cervical esophageal cancer.cervical esophageal cancerJPRN-UMIN000018241Gunma University Hospital6
Completed
N/A
Feasibility trial of neoadjuvant chemoradiotherapy in patients with locally advanced gastric cancerGastric cancerJPRN-UMIN000004960Department of Gastroenterological Surgery, School of Medicine, Kagawa University16
Completed
N/A
Feasibility study of neoadjuvant chemotherapy with docetaxel/CDGP/5-fluorouracil in resectable esophagus canceresophagus cancerJPRN-UMIN000014305Department of Medical Oncology, Sapporo Medical University School of Medicine28
Recruiting
N/A
A feasibility study of neoadjuvant chemotherapy with mFOLFOX6 in patients with locally metastatic rectal cancerrectal cancerJPRN-UMIN000003428Toho University school of medicine20
Completed
N/A
A feasibility study of neoadjuvant chemotherapy with docetaxel+cisplatin+capecitabine (DCX) for HER2-negative gastric cancer with macroscopic type 4 and large type 3, or with multiple lymph node metastasisGastric cancerJPRN-UMIN000026783agoya University20